--- title: "Huahaipharm's subsidiary, Ruixiqi's Bevacizumab Injection marketing authorization application has been accepted" type: "News" locale: "en" url: "https://longbridge.com/en/news/260413179.md" description: "Huahaipharm's subsidiary, Huaotai, recently received the acceptance notice for the marketing authorization application of Reciqi Bai Injection from the National Medical Products Administration. This drug is used for the treatment of adult generalized pustular psoriasis (GPP) and is the first domestically developed anti-IL-36R antibody, demonstrating good safety and efficacy" datetime: "2025-10-09T09:34:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/260413179.md) - [en](https://longbridge.com/en/news/260413179.md) - [zh-HK](https://longbridge.com/zh-HK/news/260413179.md) --- # Huahaipharm's subsidiary, Ruixiqi's Bevacizumab Injection marketing authorization application has been accepted According to the Zhitong Finance APP, Huahai Pharmaceutical (600521.SH) announced that its subsidiary Shanghai Huatai Biopharmaceutical Co., Ltd. (referred to as "Huatai") has received the "Acceptance Notice" for the domestic production drug registration application of Reciqi Baidankang (research code: HB0034) injection issued by the National Medical Products Administration. The declared indication is for the treatment of adult generalized pustular psoriasis (GPP) flare-ups. Currently, there are no domestically developed targeted IL-36R antibodies approved for marketing worldwide. As the first domestically developed innovative anti-IL-36R antibody, HB0034 can exert anti-inflammatory biological effects by inhibiting the IL-36 pathway. According to research analysis results, compared to the placebo, patients with GPP flare-ups showed significant clearance of skin pustules one week after a single intravenous administration of HB0034, achieving the primary research endpoint set by the protocol, with good safety performance and no new safety signals identified ### Related Stocks - [600521.CN](https://longbridge.com/en/quote/600521.CN.md) ## Related News & Research - [Investeringsforeningen Nykredit Invest Balance suspender handel med udvalgte afdelinger](https://longbridge.com/en/news/286877547.md) - [Release according to article 135 section 2 BörseG](https://longbridge.com/en/news/286754366.md) - [20:00 ETAccro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases](https://longbridge.com/en/news/286830151.md) - [Announcement from Eimskip: Seafarers’ Union of Iceland announces strike](https://longbridge.com/en/news/286679460.md) - [](https://longbridge.com/en/news/286948461.md)